The inflammatory burden index is a superior systemic inflammation biomarker for the prognosis of non-small cell lung cancer.
Xie H, Ruan G, Wei L, Deng L, Zhang Q, Ge Y, Song M, Zhang X, Lin S, Liu X, Yang M, Song C, Zhang X, Shi H.
Xie H, et al. Among authors: wei l.
J Cachexia Sarcopenia Muscle. 2023 Apr;14(2):869-878. doi: 10.1002/jcsm.13199. Epub 2023 Feb 28.
J Cachexia Sarcopenia Muscle. 2023.
PMID: 36852672
Free PMC article.